Schönlein C, Löffler J, Huber G
Pharma Division, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Biochem Biophys Res Commun. 1994 May 30;201(1):45-53. doi: 10.1006/bbrc.1994.1667.
The main component of amyloid plaques in Alzheimer's disease (AD) is the beta-amyloid peptide (beta/A4), derived from beta-amyloid precursor proteins (beta-APPs). In order to identify proteases possibly involved in the cleavage at the N-terminal site of beta/A4 a chromogenic peptide corresponding to this region of beta-APP was used. Here the purification and characterization of a new human brain protease with the ability to cleave the beta-APP peptide as well as beta-APP in vitro are described. The enzyme has a molecular mass of 100 kDa and belongs likely to the class of metalloproteases. It should further be named "MP100". The enzyme has a very broad substrate specificity in vitro.
阿尔茨海默病(AD)中淀粉样斑块的主要成分是β-淀粉样肽(β/A4),其来源于β-淀粉样前体蛋白(β-APPs)。为了鉴定可能参与β/A4 N端位点切割的蛋白酶,使用了与β-APP该区域相对应的生色肽。本文描述了一种新的人脑蛋白酶的纯化和特性,该酶能够在体外切割β-APP肽以及β-APP。该酶分子量为100 kDa,可能属于金属蛋白酶类。应进一步将其命名为“MP100”。该酶在体外具有非常广泛的底物特异性。